# LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors

> **NCT04690699** · PHASE1,PHASE2 · TERMINATED · sponsor: **Istari Oncology, Inc.** · enrollment: 4 (actual)

## Conditions studied

- Solid Tumor
- Bladder Cancer
- Non-muscle-invasive Bladder Cancer

## Interventions

- **BIOLOGICAL:** Lerapolturev
- **OTHER:** 5% DDM

## Key facts

- **NCT ID:** NCT04690699
- **Lead sponsor:** Istari Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-01
- **Primary completion:** 2024-04-04
- **Final completion:** 2024-06-12
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** business decision
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04690699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04690699, "LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04690699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*